Accès ouvert déclaré 2026 article

Italian healthcare professionals' real-world experience with immunization in children of non-European origin: the Vax4globe survey

Viviana Moschese, Simona Graziani, Antonietta Spadea, Maurizia d'Amore, Raffaella Mosco, Sara Ciampini, Nicola Di Giorgio, Susanna Arcano, Simona Ceccarelli, Marco Chianca, Simona Piccinini, Antonella Polito, Marta Porcari, Pamela Puliafito, Romina Silenzi, Elisabetta Del Duca, Alfonso Piciocchi, Claudio Pignata, Michele Miraglia del Giudice, Gian Luigi Marseglia

0Citations signalées, ce qui n’est pas une note de qualité

6Institutions déclarées

2Pays d’affiliation déclarés

Rattachement africain : it, gb. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Introduction Nowadays vaccine hesitancy represents a significant current global health threat, causing reduced vaccine coverage with relevant effects on vulnerable populations. This study explores Italian healthcare professionals' (HCPs) experience with immunization of non-European (non-EU) origin children to implement targeted strategies for higher vaccine coverage and a “vulnerables-friendly care”. Methods The Vax4globe survey was administered to HCPs distributed throughout the Lazio Region from February to July 2024. The survey included HCPs' demographic data and twelve items investigating vaccine compliance and barriers of non-EU origin children in their clinical practice as well as potential strategies to increase immunization. Results The survey included 101 HCPs, namely physicians and pediatricians working at vaccination centers and primary care services, caring for approximately 50,000–60,000 children overall, of which approximately 15,000 were of non–EU origin. As stated by HCPs, children's country of origin were mainly from countries in Asia (median 30%; range 0%–80%) and South America (median 20%; range 0%–30%). Of the HCPs, 88% (95% CI: 80.4–93.1) reported that ≤50% of non-EU origin parents were able to provide evidence of their children's immunizations and, according to 80% (95% CI: 71.4–86.8) of HCPs, the Italian National Vaccination Prevention Plan (PNPV) was appropriate in ≤50% of children at first assessment. Therefore, according to HCPs, the vaccination record of the country of origin is essential to verify the immunization status (57%), PNPV vaccines should be recommended according to patient's age and documented immunization status (62%), and priority should be given to mandatory vaccines in children under 7 years of age not compliant with the PNPV (96%). In our survey, adherence to PNPV vaccines was significantly higher than to Sars-CoV-2 vaccine in pediatric age patients (immunization adherence <10%: 3% PNPV vs. 48% Sars-CoV-2; immunization adherence >90%: 42.5% PNPV vs. 0% Sars-CoV-2) ( p < 0.0001). Similarly, the adherence to Sars-CoV-2 vaccine was lower in children than in their parents (immunization adherence <10%: 48% vs. 17%, respectively) ( p < 0.0001). Finally, according to HCPs, the main barriers to vaccine adherence were linguistic and socio-cultural (75%;95% CI: 66.0–82.6) for PNPV vaccines and safety concerns (52%; 95% CI: 42.8–61.9) for the Sars-CoV-2 vaccine. Discussion Our study reports a real-world picture of immunization among non-EU origin children by Italian HCPs and highlights the need for targeted strategies to overcome factors affecting vaccine hesitancy. To date, vaccine health equity is far from being achieved.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref: Italian healthcare professionals' real-world experience with immunization in children of non-European origin: the Vax4globe survey
Date Crossref: 09/06/2026
Éditeur: Frontiers Media SA
Type: journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Où se fait cette recherche

Policlinico Tor Vergata pays non établi dans la notice
Établissement de santé
Public Health Agency pays non établi dans la notice
Institution
Fondazione Gimema Onlus pays non établi dans la notice
Organisation à but non lucratif
Federico II University Hospital Department of Translational Medical Science pays non établi dans la notice
Établissement de santé
University of Campania "Luigi Vanvitelli" pays non établi dans la notice
Université ou école supérieure
University of Pavia Department of Clinical pays non établi dans la notice
Université ou école supérieure
University of Rome Tor Vergata Policlinico Tor Vergata pays non établi dans la notice
Université ou école supérieure
Local Health Agency RM2 pays non établi dans la notice
Organisme public
Vaccination Complex Operational Unit of Local Health Agency Rome 1 pays non établi dans la notice
Organisme public
Local Health Agency Rome 6 UOC District Management 6.6 pays non établi dans la notice
Organisme public
Local Health Agency RM5 pays non établi dans la notice
Organisme public
Local Health Agency RM1 pays non établi dans la notice
Organisme public

Policlinico Tor Vergata, Public Health Agency et Fondazione Gimema Onlus, avec 9 autres affiliations.

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Vaccine Coverage and HesitancyInfluenza Virus Research StudiesImmune responses and vaccinations

Lire en accès ouvert Consulter la publication primaire Ouvrir le DOI